Welcome and Introduction
Roger R. Dmochowski, MD

Eulogy - Ahmed Elbadawi, MD
Subbarao V. Yalla, MD

State of the Art: The Terminology of Male Voiding Dysfunction
Alan J. Wein, MD, PhD (Hon)

Outcomes Reporting and Journal Oversight
John M. Fitzpatrick, MD

Discussion and Questions

EVALUATION AND ASSESSMENT OF MALE LUTS
Moderator: Gary E. Lemack, MD

Symptom Assessment and QOL
David F. Penson, MD, MPH

Urodynamics
Jerry G. Blaivas, MD

New Modalities
Sender Herschorn, MD

Case Analysis
Gary E. Lemack, MD

PHARMACOTHERAPY FOR MALE LUTS
Moderator: Stephen R. Kraus, MD

Antimuscarinics
Christopher R. Chapple, Bsc, MD, FRCS

Alpha Blockers
Claus G. Roehrborn, MD

Combination Therapy
Steven A. Kaplan, MD

Phosphodiesterase Inhibitors
Stephen R. Kraus, MD

Beta Three Agonists
Melissa R. Kaufman, MD, PhD

The Future
Karl-Erik Andersson, MD, PhD

INVASIVE THERAPY FOR MALE LUTS
Moderator: Douglas F. Milam, MD

Current Status of Thermotherapy
James C. Ulchaker, MD, FACS

TURP
Alexander Gomelsky, MD

Neurotoxin
Sandip P. Vasavada, MD

Neuromodulation
Ajay K. Singla, MD

Case Discussions
Douglas F. Milam, MD